AusPAR: Influenza Virus Haemagglutinin H5N1
Related information
- Australian Public Assessment Reports for prescription medicines (AusPARs)
- Browse AusPARs by active ingredient
- Browse AusPARs by product name
- Browse AusPARs by sponsor
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
20 July 2011
| AusPAR | |
|---|---|
| Active Ingredient | Influenza Virus Haemagglutinin H5N1
|
| Product Name | Prepandemic H5N1 adjuvanted Influenza Vaccine / Aflunov
|
| Sponsor | Novartis Vaccines and Diagnostics Pty Ltd
|
| Submission Number | PM-2009-03929-3-2
|
| Submission Type | New biosimilar medicine similar to other pandemic and seasonal influenza vaccines
|
| AusPAR Date | 6 July 2011
|
| Publication Date | 20 July 2011 |